American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 387-393 , August 2010

A Physiologic-Based Approach to the Evaluation of a Patient With Hyperkalemia

  • Biff F. Palmer, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Biff F. Palmer, MD, Professor of Internal Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390

Received 27 November 2009 ,Accepted 4 January 2010.

References 

  1. Shingarev R, Allon M. A physiologic approach to the treatment of acute hyperkalemia [published online ahead of print 2010]. Am J Kidney Dis. doi: 10.1053/j.ajkd.2010.03.014.
  2. Abu-Hamdan DK, Sondheimer JH, Mahajan SK. Cautopyreiophagia (Cause of life-threatening hyperkalemia in a patient undergoing hemodialysis). Am J Med. 1985;79(4):517–519
  3. Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19(3):424–426
  4. Palmer BF, Sterns R. Fluid, electrolyte and acid-base disturbances. NephSAP. 2009;8:70–165
  5. Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol. 2009;20(2):251–254
  6. Perazella MA. Drug-induced hyperkalemia: old culprits and new offenders. Am J Med. 2000;109(4):307–314
  7. Gamba G. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol Renal Physiol. 2005;288(2):F245–F252
  8. Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324–330
  9. Putcha N, Allon M. Management of hyperkalemia in dialysis patients. Semin Dial. 2007;20(5):431–439
  10. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585–592
  11. Einhorn LM, Zhan M, Hsu VD, et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med. 2009;169(12):1156–1162
  12. Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT. Upper gastrointestinal tract injury in patients receiving Kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic and histopathologic findings. Am J Surg Pathol. 2001;25(5):637–644

 Originally published online as doi:10.1053/j.ajkd.2010.01.020 on May 21, 2010.

PII: S0272-6386(10)00492-0

doi: 10.1053/j.ajkd.2010.01.020

American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 387-393 , August 2010

Article Tools

* Image Usage & Resolution